Patients in the operating theatre metabolise less than 5% of inhalational anaesthetic delivered. The rest is exhaled, unchanged, and extracted to the atmosphere.
The inhalational anaesthetic market is worth $1.2bn p.a. globally, and the market is growing at 3.5% CAGR.
However, inhalational anaesthetics are potent greenhouse gases (HFCs) whose emissions are not currently enforced under environmental regulations such as the UN’s Montreal Protocol and the EU’s F-gas Regulations because they are essential for medical use. Globally, the environmental impact is 3m tonnes of CO2e p.a.
SageTech has developed a patented process that captures, extracts and purifies inhalational anaesthetic agents. Our aim is to reduce the carbon footprint of anaesthesia on a global scale.
Our holistic approach ensures that inhalational agent recycling is a viable commercial proposition.